NCT07037953View on ClinicalTrials.gov

Association of Serum circ_DLGAP4, lncRNA KCNQ1OT1, and Their Targets miR-9 and SOX7 With Early Diagnosis, Erythropoietin Resistance and Worse Clinical Outcomes of Chronic Kidney Disease: Insights From Hemodialysis Patients

Active, not recruitingOBSERVATIONAL

Enrollment

180

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

July 1, 2025

Conditions

Chronic Kidney Disease Requiring HemodialysisChronic Kidney Disease

Trial Locations (1)

Unknown

Unit of Renal Failure Therapy and Surgery, Kasr Al-Ainy Hospital, Faculty of Medicine, Cairo, Egypt, and the Hemodialysis Unit, New Cairo Specialized Hospital, Cairo, Egypt, Cairo

All Listed Sponsors

collaborator

Egyptian Chinese University

OTHER

collaborator

Kasr El Aini Hospital

OTHER

lead

Ain Shams University

OTHER